 | Up a level |
Koch, Elias A. T., Petzold, Anne, Wessely, Anja 
ORCID: 0000-0003-1940-5115, Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica C., Haferkamp, Sebastian ORCID: 0000-0002-3894-8345, Hohberger, Bettina, Kaehler, Katharina C., Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund, Meissner, Markus, Mohr, Peter, Pfoehler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk, Schell, Beatrice, Schlaak, Max, Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma, Ulrich, Jens, Utikal, Jochen, Weichenthal, Michael, Ziller, Fabian, Berking, Carola and Heppt, Markus V.
(2021).
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis.
Cancers, 13 (13).
BASEL:
MDPI.
ISSN 2072-6694
Koch, Elias A. T., Petzold, Anne, Wessely, Anja ORCID: 0000-0003-1940-5115, Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica C., Haferkamp, Sebastian, Kaehler, Katharina C., Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike ORCID: 0000-0002-8019-1577, Loquai, Carmen, Meier, Friedegund ORCID: 0000-0003-4340-9706, Meissner, Markus ORCID: 0000-0002-5630-587X, Mohr, Peter ORCID: 0000-0002-7328-7407, Pfoehler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk ORCID: 0000-0003-3524-7858, Schell, Beatrice, Schlaak, Max ORCID: 0000-0002-1663-8098, Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma ORCID: 0000-0002-9384-6704, Ulrich, Jens, Utikal, Jochen ORCID: 0000-0001-5316-0241, Weichenthal, Michael ORCID: 0000-0002-9060-4961, Ziller, Fabian, Berking, Carola ORCID: 0000-0003-0229-8931 and Heppt, Markus V.
(2022).
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity.
Cancers, 14 (3).
BASEL:
MDPI.
ISSN 2072-6694
Schumann, Katharina, Mauch, Cornelia, Klespe, Kai-Christian, Loquai, Carmen, Nikfarjam, Ulrike, Schlaak, Max, Akcetin, Larissa, Koelblinger, Peter, Hoellwerth, Magdalena ORCID: 0000-0002-2771-4041, Meissner, Markus, Mengi, Guelcin, Braun, Andreas Dominik, Mengoni, Miriam, Dummer, Reinhard, Mangana, Joanna, Sindrilaru, Mihaela-Anca, Radmann, Dan, Hafner, Christine, Freund, Johann, Rappersberger, Klemens, Weihsengruber, Felix, Meiss, Frank, Reinhardt, Lydia, Meier, Friedegund ORCID: 0000-0003-4340-9706, Rainer, Barbara, Richtig, Erika, Ressler, Julia Maria ORCID: 0000-0001-8602-0878, Hoeller, Christoph, Eigentler, Thomas, Amaral, Teresa, Peitsch, Wiebke K., Hillen, Uwe, Harth, Wolfgang, Ziller, Fabian, Schatton, Kerstin, Gambichler, Thilo, Susok, Laura, Maul, Lara Valeska, Laubli, Heinz, Debus, Dirk, Weishaupt, Carsten, Boerger, Sevil, Sievers, Katharina, Haferkamp, Sebastian, Zenderowski, Veronika, Nguyen, Van Anh, Wanner, Marina, Gutzmer, Ralf, Terheyden, Patrick, Kaehler, Katharina, Emmert, Steffen, Thiem, Alexander, Sachse, Michael, Gercken-Riedel, Silke, Kaune, Kjell Matthias, Thoms, Kai-Martin, Heinzerling, Lucie, Heppt, Markus Vincent, Tratzmiller, Sabine, Hoetzenecker, Wolfram, Oellinger, Angela, Steiner, Andreas, Peinhaupt, Tobias, Podda, Maurizio, Schmid, Sabine, Wollina, Uwe, Biedermann, Tilo and Posch, Christian
.
Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
J. Eur. Acad. Dermatol. Venereol..
HOBOKEN:
WILEY.
ISSN 1468-3083